DOI QR코드

DOI QR Code

Immunogenicity of Exosomes from Dendritic Cells Stimulated with Toxoplasma gondii Lysates in Ocularly Immunized Mice

  • Jung, Bong-Kwang (Institute of Parasitic Diseases, Korea Association of Health Promotion) ;
  • Kim, Eun-Do (Department of Ophthalmology, Severance Eye Hospital, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine) ;
  • Song, Hyemi (Institute of Parasitic Diseases, Korea Association of Health Promotion) ;
  • Chai, Jong-Yil (Institute of Parasitic Diseases, Korea Association of Health Promotion) ;
  • Seo, Kyoung Yul (Department of Ophthalmology, Severance Eye Hospital, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine)
  • Received : 2019.12.20
  • Accepted : 2020.03.23
  • Published : 2020.04.30

Abstract

Immunogenicity of dendritic cell-derived exosomes stimulated with Toxoplasma gondii lysates (TLA exo), mixed with cholera toxin as an adjuvant, was investigated in mice immunized via 2 mucosal routes (ocular vs intranasal). BALB/c mice were injected 3 times with TLA exo vaccine at 2 week interval, and the levels of IgG in serum and IgA in tear, saliva, feces, and vaginal wash were measured. To observe the expression of T. gondii-specific B1 gene, mice infected with ME49 T. gondii cysts were immunized with TLA exo or PBS exo (not stimulated with TLA), and their brain tissues were examined. The mice vaccinated via intranasal route elicited significantly higher humoral and mucosal immune responses compared with mice treated with PBS alone. Also, mice immunized via ocular route (by eyedrop) induced significantly higher T. gondii-specific IgG in serum and IgA in tear and feces in comparison with PBS controls. B1 gene expression was significantly lower in TLA exo vaccinated mice than in PBS or PBS exo vaccinated mice. These results demonstrated that ocular immunization of mice with TLA exo vaccine has the potential to stimulate systemic or local antibody responses. This study also highlighted an advantage of an eyedrop vaccine as an alternative for T. gondii intranasal vaccines.

Keywords

References

  1. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000; 30: 1217-1258. https://doi.org/10.1016/S0020-7519(00)00124-7
  2. Aline F, Bout D, Amigorena S, Roingeard P, Dimier-Poisson I. Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection. Infect Immun 2004; 72: 4127-4137. https://doi.org/10.1128/IAI.72.7.4127-4137.2004
  3. Dubey JP. Toxoplasmosis in sheep-the last 20 years. Vet Parasitol 2009; 163: 1-14 https://doi.org/10.1016/j.vetpar.2009.02.026
  4. Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005; 11(suppl): 45-53.
  5. Zheng Z, Diaz-Arevalo D, Guan H, Zeng M. Noninvasive vaccination against infectious diseases. Hum Vaccin Immunother 2018; 14: 1717-1733. https://doi.org/10.1080/21645515.2018.1461296
  6. Chung JR, Flannery B, Ambrose CS, Begue RE, Caspard H, DeMarcus L, Fowlkes AL, Kersellius G, Steffens A, Fry AM. Live attenuated and inactivated influenza vaccine effectiveness. Pediatrics 2019; 143: e20182094 https://doi.org/10.1542/peds.2018-2094
  7. Seo KY, Han SJ, Cha HR, Seo SU, Song JH, Chung SH, Kweon MN. Eye mucosa: an efficient vaccine delivery route for inducing protective immunity. J Immunol 2010; 185: 3610-3619. https://doi.org/10.4049/jimmunol.1000680
  8. Yoon S, Kim ED, Song MS, Han SJ, Park TK, Choi KS, Choi YK, Seo KY. Eyedrop vaccination induced systemic and mucosal immunity against influenza virus in ferrets. PLoS One 2016; 11: e0157634. https://doi.org/10.1371/journal.pone.0157634
  9. Kim ED, Han SJ, Byun YH, Yoon SC, Choi KS, Seong BL, Seo KY. Inactivated eyedrop influenza vaccine adjuvanted with poly (I:C) is safe and effective for inducing protective systemic and mucosal immunity. PLoS One 2015; 10: e0137608. https://doi.org/10.1371/journal.pone.0137608
  10. Silverman JM, Clos J, Horakova E, Wang AY, Wiesgigl M, Kelly I, Lynn MA, McMaster WR, Foster LJ, Levings MK, Reiner NE. Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells. J Immunol 2010; 185: 5011-5022. https://doi.org/10.4049/jimmunol.1000541
  11. Zamanian M, Fraser LM, Agbedanu PN, Harischandra H, Moorhead AR, Day TA, Bartholomay LC, Kimber MJ. Release of small RNA-containing exosome-like vesicles from the human filarial parasite Brugia malayi. PLoS Negl Trop Dis 2015; 9: e0004069. https://doi.org/10.1371/journal.pntd.0004069
  12. Buck AH, Coakley G, Simbari F, McSorley HJ, Quintana JF, Le Bihan T, Kumar S, Abreu-Goodger C, Lear M, Harcus Y, Ceroni A, Babayan SA, Blaxter M, Ivens A, Maizels RM. Exosomes secreted by nematode parasites transfer small RNAs to mammalian cells and modulate innate immunity. Nat Commun 2014; 5: 5488. https://doi.org/10.1038/ncomms6488
  13. Keller S, Sanderson MP, Stoeck A, Altevogt P. Exosomes: from biogenesis and secretion to biological function. Immunol Lett 2006; 107: 102-108. https://doi.org/10.1016/j.imlet.2006.09.005
  14. Jung BK, Pyo KH, Shin K, Hwang Y, Lim H, Lee S, Moon JH, Lee S, Suh YH, Chai JY, Shin EH. Toxoplasma gondii infection in the brain inhibits neuronal degeneration and learning and memory impairments in a murine model of Alzheimer's disease. PLoS One 2012; 7: e33312. https://doi.org/10.1371/journal.pone.0033312
  15. Perez-Hernandez J, Forner MJ, Pinto C, Chaves F, Cortes R, Redon J. Increased urinary exosomal microRNAs in patients with systemic lupus erythematosus. PLoS One 2015; 10: e0138618. https://doi.org/10.1371/journal.pone.0138618
  16. Jungbauer A. Exosomes enter vaccine development: strategies meeting global challenges of emerging infections. Biotechnol J 2018; 13: e1700749. https://doi.org/10.1002/biot.201700749
  17. Anticoli S, Manfredi F, Chiozzini C, Arenaccio C, Olivetta E, Ferrantelli F, Capocefalo A, Falcone E, Ruggieri A, Federico M. An exosome-based vaccine platform imparts cytotoxic T lymphocyte immunity against viral antigens. Biotechnol J 2018; 13: e1700443.
  18. Schnitzer JK, Berzel S, Fajardo-Moser M, Remer KA, Moll H. Fragments of antigen-loaded dendritic cells (DC) and DC-derived exosomes induce protective immunity against Leishmania major. Vaccine 2010; 28: 5785-5793. https://doi.org/10.1016/j.vaccine.2010.06.077
  19. Sotillo J, Pearson M, Potriquet J, Becker L, Pickering D, Mulvenna J, Loukas A. Extracellular vesicles secreted by Schistosoma mansoni contain protein vaccine candidates. Int J Parasitol 2016; 46: 1-5. https://doi.org/10.1016/j.ijpara.2015.09.002
  20. Shears RK, Bancroft AJ, Hughes GW, Grencis RK, Thornton DJ. Extracellular vesicles induce protective immunity against Trichuris muris. Parasite Immunol 2018; 40: e12536. https://doi.org/10.1111/pim.12536
  21. Eichenberger RM, Sotillo J, Loukas A. Immunobiology of parasitic worm extracellular vesicles. Immunol Cell Biol 2018; 96: 704-713. https://doi.org/10.1111/imcb.12171

Cited by

  1. Chemically Engineered Immune Cell‐Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools vol.8, pp.8, 2020, https://doi.org/10.1002/advs.202002499